Dr Sitaram Velaga, PhD

Dr. Sitaram Velaga provides strategic and scientific leadership to the Onconox Board, guiding the company’s long-term vision and platform expansion strategy. As founder and architect of the BIG Platform, he has been central to establishing Onconox’s differentiated model for precision drug delivery in oncology and CNS diseases. His oversight ensures the company maintains a disciplined balance between innovation, scientific rigor, and capital efficiency. Dr. Velaga brings extensive experience in drug development, formulation science, and regulatory engagement, and plays a key role in shaping the company’s translational and clinical roadmap as it advances toward multiple IND filings.